OOIR: Observatory of International Research

Papers

(The TQCC of Cellular & Molecular Biology Letters is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	139
Targeting microRNAs with thymoquinone: a new approach for cancer therapy	137
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	135
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	124
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	111
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	110
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	103
Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells	99
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1	93
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges	93
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	91
lncRNA PVT1: a novel oncogene in multiple cancers	88
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis	78
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review	77
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis	76
Osteoporosis pathogenesis and treatment: existing and emerging avenues	70
Mitochondrial potassium channels: A novel calcitriol target	66
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L	60
The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation	59
Melatonin and cancer suppression: insights into its effects on DNA methylation	57
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells	54
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo	53
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation	51
COVID-19 therapies: do we see substantial progress?	51
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress	50

Esterase D stabilizes FKBP25 to suppress mTORC1	48
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration	48
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner	48
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma	46
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma	45
Diversification of PAR signaling through receptor crosstalk	45
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications	42